|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 413/12 |
| (11) | Patento numeris | 2545048 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11714473.3 |
| Europos patento paraiškos padavimo data | 2011-04-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-01-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-10-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/030892 |
| Data | 2011-04-01 |
| (87) | Numeris | WO 2011/123754 |
| Data | 2011-10-06 |
| (30) | Numeris | Data | Šalis |
| 392770 P | 2010-10-13 | US | |
| 392759 P | 2010-10-13 | US | |
| 417632 P | 2010-11-29 | US | |
| 329284 P | 2010-04-29 | US | |
| 320062 P | 2010-04-01 | US | |
| 353398 P | 2010-06-10 | US | |
| 326922 P | 2010-04-22 | US |
| (72) |
KWOKAL, Ana, HR
HEDVATI, Lilach, IL
BURSTEIN, Revital, IL
YEORI, Adi, IL
MOSHKOVITS-KAPTSAN, Rinat, IL
|
| (73) |
Teva Pharmaceutical Industries Ltd.,
5 Basel Street P.O. Box 3190, 49131 Petah Tiqva,
IL
|
| (54) | RALTEGRAVIR SALTS AND CRYSTALLINE FORMS THEREOF |
| RALTEGRAVIR SALTS AND CRYSTALLINE FORMS THEREOF |